TAB3 Antikörper (AA 361-712)
Kurzübersicht für TAB3 Antikörper (AA 361-712) (ABIN7171966)
Target
Alle TAB3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 361-712
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human TGF-beta-activated kinase 1 and MAP3K7-binding protein 3 protein (361-712AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- TAB3 (TGF-beta Activated Kinase 1/MAP3K7 Binding Protein 3 (TAB3))
-
Andere Bezeichnung
- TAB3
-
Hintergrund
-
Background: Adapter linking MAP3K7/TAK1 and TRAF6 or TRAF2. Mediator of MAP3K7 activation, respectively in the IL1 and TNF signaling pathways. Plays a role in activation of NF-kappa-B and AP1 transcription factor. Isoform 2 may be an oncogenic factor.
Aliases: MAP3K7IP 3 antibody, Mitogen-activated protein kinase kinase kinase 7-interacting protein 3 antibody, NAP1 antibody, NF-kappa-B-activating protein 1 antibody, NFkB activating protein 1 antibody, TAB-3 antibody, Tab3 antibody, TAB3_HUMAN antibody, TAK1 binding protein 3 antibody, TAK1-binding protein 3 antibody, TGF-beta-activated kinase 1 and MAP3K7-binding protein 3 antibody, TGF-beta-activated kinase 1-binding protein 3 antibody
-
UniProt
- Q8N5C8
-
Pathways
- TLR Signalweg, Fc-epsilon Rezeptor Signalübertragung, Activation of Innate immune Response, Toll-Like Receptors Cascades
Target
-